This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignee: Pharmabcine Inc.. Active years: 2015-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2016
Sure, here is the article about inventor Weon-Sup Lee based on the given data:
Title: Innovator Spotlight: Weon-Sup Lee - Pioneering Human Monoclonal Antibodies for Cancer Treatment
Introduction:
Weon-Sup Lee, a distinguished inventor based in Daejeon, South Korea, has made significant contributions to the field of medicine with his groundbreaking work in developing human monoclonal antibodies. With a total of 3 patents to his name, Weon-Sup Lee's latest inventions focus on neutralizing vascular endothelial growth factor receptors to combat cancer effectively.
Latest Patents:
Weon-Sup Lee's latest patents revolve around the creation of human monoclonal antibodies that neutralize vascular endothelial growth factor receptors. These innovative antibodies have shown remarkable efficacy in inhibiting angiogenesis and treating cancer in both human and animal models. His inventions pave the way for advancements in anticancer studies and offer promising solutions for cancer treatment.
Career Highlights:
Weon-Sup Lee is associated with Pharmabcine Inc., a prominent pharmaceutical company known for its groundbreaking research and development in the field of medical biotechnology. His expertise and dedication have led to significant advancements in the development of novel therapies for cancer patients, showcasing his commitment to improving healthcare outcomes globally.
Collaborations:
In his research endeavors, Weon-Sup Lee has collaborated closely with esteemed colleagues such as Jin-San Yoo and Sang-Ryeol Shim. Together, they have worked tirelessly to bring innovative solutions to the forefront of cancer treatment, pooling their collective expertise to drive progress in the medical field.
Conclusion:
Weon-Sup Lee's remarkable inventions in the realm of human monoclonal antibodies for cancer treatment underscore his unwavering commitment to advancing medical science for the betterment of society. His pioneering work holds great promise for revolutionizing cancer care and underscores the crucial role of innovation in shaping the future of healthcare.
If you need further information or assistance, feel free to reach out.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile